Literature DB >> 33671384

Comparative Proteomic Study Shows the Expression of Hint-1 in Pituitary Adenomas.

Carolina Carrillo-Najar1, Daniel Rembao-Bojórquez2, Martha L Tena-Suck2, Sergio Zavala-Vega2, Noemí Gelista-Herrera2, Miguel A Ramos-Peek3, Juan L Gómez-Amador3, Febe Cazares-Raga4, Fidel de la Cruz Hernández-Hernández4, Alma Ortiz-Plata1.   

Abstract

Pituitary adenomas (PAs) can be unpredictable and aggressive tumors. No reliable markers of their biological behavior have been found. Here, a proteomic analysis was applied to identify proteins in the expression profile between invasive and non-invasive PAs to search for possible biomarkers. A histopathological and immunohistochemical (adenohypophyseal hormones, Ki-67, p53, CD34, VEGF, Flk1 antibodies) analysis was done; a proteomic map was evaluated in 64 out of 128 tumors. There were 107 (84%) invasive and 21 (16%) non-invasive PAs; 80.5% belonged to III and IV grades of the Hardy-Vezina classification. Invasive PAs (n = 56) showed 105 ± 43 spots; 86 ± 32 spots in non-invasive PAs (n = 8) were observed. The 13 most prominent spots were selected and 11 proteins related to neoplastic process in different types of tumors were identified. Hint1 (Histidine triad nucleotide-binding protein 1) high expression in invasive PA was found (11.8 ± 1.4, p = 0.005), especially at high index (>10; p = 0.0002). High Hint1 expression was found in invasive VEGF positive PA (13.8 ± 2.3, p = 0.005) and in Flk1 positive PA (14.04 ± 2.28, p = 0.006). Hint1 is related to human tumorigenesis by its interaction with signaling pathways and transcription factors. It could be related to invasive behavior in PAs. This is the first report on Hint expression in PAs. More analysis is needed to find out the possible role of Hint in these tumors.

Entities:  

Keywords:  biological behavior; biomarkers; classification; invasive; mass spectrometry; neuroendocrine tumors; pituitary adenomas; proteomic analysis

Year:  2021        PMID: 33671384     DOI: 10.3390/diagnostics11020330

Source DB:  PubMed          Journal:  Diagnostics (Basel)        ISSN: 2075-4418


  2 in total

1.  MicroRNA-146b-5p/EPHA7 axis regulates cell invasion, metastasis, proliferation, and temozolomide-induced chemoresistance via regulation of IRAK4/TRAF6/NF-κB signaling pathway in aggressive pituitary adenoma.

Authors:  Xiaohui Lou; Yeyan Cai; Haijun Zheng; Yazhuo Zhang
Journal:  Histol Histopathol       Date:  2021-11-04       Impact factor: 2.303

Review 2.  Overview of omics biomarkers in pituitary neuroendocrine tumors to design future diagnosis and treatment strategies.

Authors:  Busra Aydin; Aysegul Caliskan; Kazim Yalcin Arga
Journal:  EPMA J       Date:  2021-06-26       Impact factor: 8.836

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.